Diabetes

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses counseling points for patients taking oral non-insulin diabetes medication.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about need-to-knows for dual add on therapy to insulin.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about new strategies pharmacists can use to optimize insulin therapy.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about pharmacist "need to knows" about insulin therapy in type 2 diabetes.

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks about what CVS is doing to support the role of the pharmacist in diabetes management.

Nearly 30% of patients with diabetes have reported that injectable insulin was the most difficult part of their care regimen.

Caregivers can have trouble differentiating ulcerative colitis from Crohn's disease and inflammatory bowel disease.

Pharmacists can play a vital role helping older patients manage their diabetes.

Only 1 in 3 older adults with diabetes meet the American Diabetes Association's treatment targets for blood glucose, cholesterol, and blood pressure.

Here are new drugs for 2015 that pharmacists can expect to handle.

John Moorman, PharmD, BCPS, talks about changes in pharmacy practice to improve patient adherence to diabetes drugs as they move through transitions of care settings.

Pharmacists included in primary care teams improve antihypertensive medication management for patients with type 2 diabetes.

Women with diabetes have a considerably higher risk of developing coronary heart disease than men with diabetes.

This Continuing Education activity is supported by an educational grant from AstraZeneca LP and Novo Nordisk, Inc

This Continuing Education activity is supported by an educational grant from Sanofi-Aventis U.S.

Here are new drugs for 2015 pharmacists can expect to handle.

A study evaluating the cardiovascular safety of Merck's type 2 diabetes drug sitagliptin determined the dipeptidyl peptidase-4 inhibitor does not increase the risk for heart failure hospitalization.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some strategies to overcoming patient barriers to insulin.

For each 10 beats per minute increase in heart rate, patients faced a 23% greater risk of diabetes.

Extracts show strong activity in treatment of cervical cancer cells.

Patients with a fast resting heart rate may have a higher risk of developing type 2 diabetes.

Treatment is the first concentrated mealtime insulin analog to be approved by the FDA.

The FDA today approved a new 200 unit/mL formulation of Lilly's Humalog KwikPen for patients with type 1 and type 2 diabetes.

Drug mitigates elevated cardiovascular risk in infected patients.